NextCure (NXTC) Non-Current Debt (2018 - 2021)
NextCure (NXTC) posted quarterly Non-Current Debt of $972000.0 for Q2 2021, down 63.17% year-over-year from $2.6 million in Q2 2020, and down 30.02% quarter-over-quarter from $1.4 million in Q1 2021.
NextCure (NXTC) Non-Current Debt (2018 - 2021) Analysis & Trends
NextCure's Non-Current Debt history runs 4 years deep, the most recent figure standing at $972000.0 for Q2 2021.
- In Q2 2021, Non-Current Debt fell 63.17% year-over-year to $972000.0; the TTM figure through Jun 2021 stood at $972000.0 (down 63.17% YoY), while the FY2020 annual figure was $1.8 million, down 45.81% from the prior year.
- Non-Current Debt for Q2 2021 stood at $972000.0, down from $1.4 million in the prior quarter.
- The five-year high for Non-Current Debt was $4.7 million in Q1 2019, with the low at $73000.0 in Q4 2018.
- The 4-year median for Non-Current Debt is $2.6 million (2020), against an average of $2.6 million.
- The sharpest annual moves came in 2019 and 2021: Non-Current Debt surged 4465.75% in 2019, then tumbled 63.17% in 2021.
- NextCure's Non-Current Debt stood at $73000.0 in 2018, then soared by 4465.75% to $3.3 million in 2019, then plunged by 45.81% to $1.8 million in 2020, then tumbled by 46.18% to $972000.0 in 2021.
- Business Quant data shows NXTC's Non-Current Debt at $972000.0 in Q2 2021, $1.4 million in Q1 2021, and $1.8 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 972,000.00 |
| Mar 31, 2021 | 1.39 Mn |
| Dec 31, 2020 | 1.81 Mn |
| Sep 30, 2020 | 2.22 Mn |
| Jun 30, 2020 | 2.64 Mn |
| Mar 31, 2020 | 3.06 Mn |
| Dec 31, 2019 | 3.33 Mn |
| Sep 30, 2019 | 3.75 Mn |
| Jun 30, 2019 | 4.17 Mn |
| Mar 31, 2019 | 4.72 Mn |
| Dec 31, 2018 | 73,000.00 |